RHYTHM PHARMACEUTICALS, INC. (31)
Browse by Contract Category
Contracts
-
Underwriting Agreement, dated as of September 14, 2022, between Rhythm Pharmaceuticals, Inc. and Cowen and Company, LLC, Stifel, Nicolaus & Company, Incorporated and Wells Fargo...
(Filed With SEC on September 15, 2022)
-
Revenue Interest Financing Agreement, dated June 16, 2022, by and between the Company and entities managed by HealthCare Royalty Management, LLC
(Filed With SEC on August 3, 2022)
-
Consulting Agreement, dated September 11, 2021, by and between the Registrant and Murray Stewart, D.M., F.R.C.P
(Filed With SEC on March 1, 2022)
-
License Agreement, dated December 3, 2021, by and between the Registrant and RareStone Group Ltd
(Filed With SEC on March 1, 2022)
-
Offer Letter, dated September 1, 2021, by and between the Registrant and Linda Shapiro Manning, M.D
(Filed With SEC on November 2, 2021)
-
First Amendment to Lease, dated April 15, 2016
(Filed With SEC on March 8, 2019)
-
Summary of Non-Employee Director Compensation Policy
(Filed With SEC on March 1, 2022)
-
2022 Employment Inducement Plan Form of Restricted Stock Unit Agreement
(Filed With SEC on March 1, 2022)
-
2022 Employment Inducement Plan and Form of Option Agreement
(Filed With SEC on March 1, 2022)
-
Amendment No. 1 to Amended and Restated Investors Rights Agreement, dated January 25, 2021
(Filed With SEC on November 2, 2021)
-
Offer Letter, dated July 9, 2021, by and between the Registrant and Pamela Cramer
(Filed With SEC on August 3, 2021)
-
Offer Letter, dated September 25, 2020, by and between the Registrant and Jennifer Chien
(Filed With SEC on March 1, 2021)
-
Offer Letter, dated September 14, 2018, by and between the Registrant and Murray Stewart M.D
(Filed With SEC on March 1, 2021)
-
Offer Letter, dated May 10, 2018, by and between the Registrant and Simon D. Kelner
(Filed With SEC on March 1, 2021)
-
Summary of Non-Employee Director Compensation Policy
(Filed With SEC on March 1, 2021)
-
Underwriting Agreement, dated as of February 4, 2021, between Rhythm Pharmaceuticals, Inc. and Morgan Stanley & Co. LLC, BofA Securities, Inc., Cowen and Company, LLC and Stifel,...
(Filed With SEC on February 5, 2021)
-
Asset Purchase Agreement, dated as of January 5, 2021, by and between Rhythm Pharmaceuticals, Inc. and Alexion Pharmaceuticals, Inc
(Filed With SEC on January 5, 2021)
-
Separation Agreement, dated September 30, 2020, between Rhythm Pharmaceuticals, Inc. and Nithya Desikan
(Filed With SEC on November 2, 2020)
-
Offer Letter, dated September 4, 2020, and Indefinite Term Employment Contract, dated October 5, 2020, between Rhythm Pharmaceuticals, Inc. and Yann Mazabraud
(Filed With SEC on November 2, 2020)
-
Amendment No. 2 to Development and Manufacturing and Services Agreement, dated as of July 15, 2020, by and between the Company and Corden Pharma Brussels S.A
(Filed With SEC on August 3, 2020)
-
Offer Letter, dated July 16, 2020, between Rhythm Pharmaceuticals, Inc. and David P. Meeker, M.D
(Filed With SEC on July 21, 2020)
-
Amendment No. 1 to Development and Manufacturing and Services Agreement, dated as of February 20, 2020, by and between the Company and Corden Pharma Brussels S.A
(Filed With SEC on May 4, 2020)
-
Offer Letter, dated December 21, 2017, by and between the Company and Hunter C. Smith
(Filed With SEC on May 4, 2020)
-
Summary of Non-Employee Director Compensation Policy
(Filed With SEC on May 4, 2020)
-
Form of Restricted Stock Unit Award Agreement
(Filed With SEC on March 2, 2020)
-
Description of the Registrants Securities registered pursuant to Section 12 of the Securities Exchange Act of 1934
(Filed With SEC on March 2, 2020)
-
Consulting Agreement dated January 6, 2020
(Filed With SEC on January 8, 2020)
-
Separation Agreement and General Release dated January 6, 2020
(Filed With SEC on January 8, 2020)
-
Underwriting Agreement dated October 15, 2019
(Filed With SEC on October 16, 2019)
-
Summary of Non-Employee Director Compensation Policy
(Filed With SEC on July 25, 2019)
-
Offer Letter, dated September 13, 2017, by and between the Registrant and Lex H.T. Van der Ploeg
(Filed With SEC on March 8, 2019)